RASGRF2 and neoplasm: Flow cytometry analysis of cells obtained from the thymus, spleen and bone marrow of tumor–bearing Vav1–/–;Rasgrf2–/– and Vav1–/– animals revealed the presence of a new population characterized by the surface expression of CD3, a T–cell specific marker (Figure 2A).